Share Price and Basic Stock Data
Last Updated: January 14, 2026, 3:31 pm
| PEG Ratio | -7.54 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
GRM Overseas Ltd operates within the agricultural products sector, focusing on the production and export of rice and other commodities. The company’s recent financial performance shows a notable revenue trajectory, with total sales recorded at ₹1,262 Cr for the fiscal year ending March 2023, a rise from ₹1,098 Cr in the previous fiscal year. However, the company faced a decline in sales for the fiscal year ending March 2025, which stood at ₹912 Cr, indicating a significant downturn. Quarterly sales figures exhibit volatility, with a peak of ₹359.38 Cr in March 2023, followed by a steep drop to ₹165.60 Cr in September 2023. This fluctuation raises concerns about demand stability and market conditions, which could be influenced by agricultural yield and pricing dynamics. Overall, while GRM Overseas has shown growth in the past, the recent downturn necessitates a closer examination of its operational strategies and market positioning to sustain revenue generation.
Profitability and Efficiency Metrics
GRM Overseas Ltd reported a net profit of ₹54 Cr for the fiscal year ending March 2023, reflecting a decrease from ₹79 Cr in the prior year. The operating profit margin (OPM) for the same period stood at 7%, which is relatively healthy compared to industry averages but has shown fluctuations, with a low of 4.29% in the latest quarter. The interest coverage ratio (ICR) was recorded at 5.12x, indicating the company’s ability to cover interest expenses comfortably. However, the return on equity (ROE) was reported at 14.6%, while the return on capital employed (ROCE) was lower at 12.1%. Such metrics suggest that while GRM Overseas maintains a reasonable profitability level, its efficiency in generating returns from its capital is under pressure, particularly as seen in the declining OPM and fluctuating net profits. This scenario necessitates a strategic reassessment of cost management and operational efficiency to enhance profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of GRM Overseas Ltd reflects a mixed picture of financial health. Total borrowings stood at ₹211 Cr against reserves of ₹420 Cr as of September 2025, indicating a manageable debt level relative to its equity base. The debt-to-equity ratio is approximately 0.93, which is within acceptable limits for the industry, suggesting a balanced approach to leveraging. However, the cash conversion cycle (CCC) has increased significantly to 329 days, highlighting potential inefficiencies in inventory management and receivables collection. This extended cycle can strain liquidity and operational flexibility. Financial ratios such as the current ratio at 1.73 and quick ratio at 1.09 indicate that the company maintains sufficient liquidity to meet short-term obligations. Yet, the price-to-book value ratio is at 4.05x, suggesting that the stock may be overvalued compared to its net asset value, which could deter potential investors if not justified by future growth prospects.
Shareholding Pattern and Investor Confidence
The shareholding structure of GRM Overseas Ltd shows a strong promoter holding of 68.19%, which reflects a significant level of control by the founding members. Foreign institutional investors (FIIs) have gradually increased their stake to 3.36%, while domestic institutional investors (DIIs) hold 1.82%. The public shareholding comprises 26.63%, indicating a diverse investor base. However, the gradual decline in promoter holdings from 72% in December 2022 to the current level may raise concerns regarding insider confidence in the company’s future. Additionally, the number of shareholders has seen fluctuations, with a peak of 34,199 in September 2024, but a reduction to 23,083 by September 2025. This trend may suggest a decline in investor interest or confidence, which could impact the company’s market performance unless addressed through strategic communication and engagement with stakeholders.
Outlook, Risks, and Final Insight
The outlook for GRM Overseas Ltd is characterized by both opportunities and challenges. On one hand, the company’s established position in the agricultural sector provides a solid foundation for recovery, especially if market conditions improve and demand stabilizes. However, the recent decline in revenues and profits raises significant concerns. Key risks include the volatility in agricultural prices, which can impact profit margins, and the increasing cash conversion cycle that may hinder operational efficiency. Additionally, competition within the sector can exert pressure on pricing and market share. To navigate these challenges, GRM Overseas must adopt strategies that focus on enhancing operational efficiencies, managing costs effectively, and potentially diversifying its product offerings. The company’s ability to respond to these risks will be critical in determining its future trajectory in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 3,135 Cr. | 170 | 186/64.4 | 59.2 | 23.5 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 147 Cr. | 184 | 200/105 | 65.6 | 165 | 0.00 % | 7.35 % | 8.07 % | 10.0 |
| City Crops Agro Ltd | 30.7 Cr. | 18.8 | 28.4/17.0 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,283 Cr. | 258 | 396/242 | 13.6 | 153 | 0.96 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 401 Cr. | 12.1 | 18.5/11.5 | 14.4 | 6.86 | 0.08 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,620.90 Cr | 236.12 | 30.08 | 106.69 | 0.34% | 11.80% | 12.33% | 4.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 258.97 | 330.83 | 359.38 | 297.32 | 165.60 | 357.47 | 365.44 | 275.90 | 149.92 | 244.51 | 242.82 | 255.93 | 290.86 |
| Expenses | 240.74 | 310.28 | 341.56 | 275.54 | 158.04 | 342.10 | 350.99 | 255.29 | 141.82 | 234.91 | 215.90 | 235.71 | 278.38 |
| Operating Profit | 18.23 | 20.55 | 17.82 | 21.78 | 7.56 | 15.37 | 14.45 | 20.61 | 8.10 | 9.60 | 26.92 | 20.22 | 12.48 |
| OPM % | 7.04% | 6.21% | 4.96% | 7.33% | 4.57% | 4.30% | 3.95% | 7.47% | 5.40% | 3.93% | 11.09% | 7.90% | 4.29% |
| Other Income | -0.46 | 8.05 | 3.70 | 5.54 | 6.61 | 8.59 | 11.48 | 5.16 | 4.72 | 10.98 | 4.46 | 7.68 | 5.25 |
| Interest | 3.18 | 5.49 | 5.76 | 5.53 | 4.08 | 5.13 | 5.74 | 3.55 | 2.44 | 3.75 | 7.95 | 5.43 | 5.09 |
| Depreciation | 0.74 | 0.79 | 1.36 | 0.83 | 0.84 | 0.86 | 1.01 | 0.69 | 0.76 | 0.71 | 0.81 | 0.77 | 0.75 |
| Profit before tax | 13.85 | 22.32 | 14.40 | 20.96 | 9.25 | 17.97 | 19.18 | 21.53 | 9.62 | 16.12 | 22.62 | 21.70 | 11.89 |
| Tax % | 24.55% | 26.52% | 38.61% | 25.19% | 26.81% | 26.21% | 18.20% | 25.27% | 25.99% | 25.87% | 29.93% | 24.79% | 25.90% |
| Net Profit | 10.44 | 16.40 | 8.85 | 15.68 | 6.77 | 13.26 | 15.68 | 16.08 | 7.12 | 11.95 | 15.86 | 16.32 | 8.81 |
| EPS in Rs | 0.58 | 0.91 | 0.49 | 0.87 | 0.38 | 0.74 | 0.87 | 0.89 | 0.40 | 0.66 | 0.88 | 0.89 | 0.48 |
Last Updated: December 26, 2025, 5:05 pm
Below is a detailed analysis of the quarterly data for GRM Overseas Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 290.86 Cr.. The value appears strong and on an upward trend. It has increased from 255.93 Cr. (Jun 2025) to 290.86 Cr., marking an increase of 34.93 Cr..
- For Expenses, as of Sep 2025, the value is 278.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 235.71 Cr. (Jun 2025) to 278.38 Cr., marking an increase of 42.67 Cr..
- For Operating Profit, as of Sep 2025, the value is 12.48 Cr.. The value appears to be declining and may need further review. It has decreased from 20.22 Cr. (Jun 2025) to 12.48 Cr., marking a decrease of 7.74 Cr..
- For OPM %, as of Sep 2025, the value is 4.29%. The value appears to be declining and may need further review. It has decreased from 7.90% (Jun 2025) to 4.29%, marking a decrease of 3.61%.
- For Other Income, as of Sep 2025, the value is 5.25 Cr.. The value appears to be declining and may need further review. It has decreased from 7.68 Cr. (Jun 2025) to 5.25 Cr., marking a decrease of 2.43 Cr..
- For Interest, as of Sep 2025, the value is 5.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.43 Cr. (Jun 2025) to 5.09 Cr., marking a decrease of 0.34 Cr..
- For Depreciation, as of Sep 2025, the value is 0.75 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.77 Cr. (Jun 2025) to 0.75 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 11.89 Cr.. The value appears to be declining and may need further review. It has decreased from 21.70 Cr. (Jun 2025) to 11.89 Cr., marking a decrease of 9.81 Cr..
- For Tax %, as of Sep 2025, the value is 25.90%. The value appears to be increasing, which may not be favorable. It has increased from 24.79% (Jun 2025) to 25.90%, marking an increase of 1.11%.
- For Net Profit, as of Sep 2025, the value is 8.81 Cr.. The value appears to be declining and may need further review. It has decreased from 16.32 Cr. (Jun 2025) to 8.81 Cr., marking a decrease of 7.51 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.48. The value appears to be declining and may need further review. It has decreased from 0.89 (Jun 2025) to 0.48, marking a decrease of 0.41.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 422 | 568 | 355 | 591 | 924 | 1,068 | 739 | 748 | 1,098 | 1,262 | 1,186 | 912 | 1,034 |
| Expenses | 406 | 544 | 341 | 571 | 889 | 1,026 | 687 | 690 | 1,013 | 1,177 | 1,127 | 846 | 965 |
| Operating Profit | 16 | 24 | 14 | 20 | 35 | 42 | 52 | 59 | 85 | 86 | 59 | 65 | 69 |
| OPM % | 4% | 4% | 4% | 3% | 4% | 4% | 7% | 8% | 8% | 7% | 5% | 7% | 7% |
| Other Income | -0 | -0 | 0 | -0 | 0 | 1 | 13 | 5 | 37 | 12 | 32 | 25 | 28 |
| Interest | 7 | 14 | 9 | 10 | 15 | 16 | 14 | 12 | 13 | 19 | 20 | 18 | 22 |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 3 | 3 |
| Profit before tax | 7 | 8 | 3 | 8 | 18 | 25 | 48 | 49 | 106 | 75 | 67 | 70 | 72 |
| Tax % | 33% | 42% | 34% | 34% | 35% | 35% | 24% | 25% | 26% | 28% | 24% | 27% | |
| Net Profit | 5 | 5 | 2 | 6 | 12 | 16 | 36 | 37 | 79 | 54 | 51 | 51 | 53 |
| EPS in Rs | 0.88 | 0.83 | 0.37 | 1.01 | 2.12 | 2.94 | 6.55 | 6.20 | 13.14 | 8.93 | 8.56 | 8.50 | 8.73 |
| Dividend Payout % | 15% | 0% | 0% | 0% | 16% | 11% | 5% | 22% | 70% | 5% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | -60.00% | 200.00% | 100.00% | 33.33% | 125.00% | 2.78% | 113.51% | -31.65% | -5.56% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -60.00% | 260.00% | -100.00% | -66.67% | 91.67% | -122.22% | 110.74% | -145.16% | 26.09% | 5.56% |
GRM Overseas Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 4% |
| 3 Years: | -6% |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 7% |
| 3 Years: | -14% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 55% |
| 5 Years: | 74% |
| 3 Years: | -8% |
| 1 Year: | 38% |
| Return on Equity | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 24% |
| 3 Years: | 18% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 3:40 pm
Balance Sheet
Last Updated: December 10, 2025, 4:25 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 26 | 31 | 33 | 38 | 50 | 64 | 98 | 135 | 192 | 243 | 294 | 380 | 420 |
| Borrowings | 143 | 155 | 132 | 198 | 292 | 348 | 210 | 188 | 331 | 407 | 393 | 364 | 211 |
| Other Liabilities | 38 | 55 | 15 | 59 | 64 | 62 | 60 | 89 | 119 | 99 | 38 | 109 | 178 |
| Total Liabilities | 211 | 244 | 183 | 299 | 410 | 478 | 372 | 416 | 655 | 761 | 737 | 865 | 821 |
| Fixed Assets | 22 | 22 | 21 | 21 | 21 | 31 | 37 | 35 | 36 | 37 | 36 | 39 | 38 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 0 | 2 | 2 | 12 | 12 |
| Other Assets | 189 | 222 | 162 | 278 | 387 | 442 | 333 | 380 | 618 | 722 | 700 | 814 | 771 |
| Total Assets | 211 | 244 | 183 | 299 | 410 | 478 | 372 | 416 | 655 | 761 | 737 | 865 | 821 |
Below is a detailed analysis of the balance sheet data for GRM Overseas Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Reserves, as of Sep 2025, the value is 420.00 Cr.. The value appears strong and on an upward trend. It has increased from 380.00 Cr. (Mar 2025) to 420.00 Cr., marking an increase of 40.00 Cr..
- For Borrowings, as of Sep 2025, the value is 211.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 364.00 Cr. (Mar 2025) to 211.00 Cr., marking a decrease of 153.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 178.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 109.00 Cr. (Mar 2025) to 178.00 Cr., marking an increase of 69.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 821.00 Cr.. The value appears to be improving (decreasing). It has decreased from 865.00 Cr. (Mar 2025) to 821.00 Cr., marking a decrease of 44.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Other Assets, as of Sep 2025, the value is 771.00 Cr.. The value appears to be declining and may need further review. It has decreased from 814.00 Cr. (Mar 2025) to 771.00 Cr., marking a decrease of 43.00 Cr..
- For Total Assets, as of Sep 2025, the value is 821.00 Cr.. The value appears to be declining and may need further review. It has decreased from 865.00 Cr. (Mar 2025) to 821.00 Cr., marking a decrease of 44.00 Cr..
Notably, the Reserves (420.00 Cr.) exceed the Borrowings (211.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -127.00 | -131.00 | -118.00 | -178.00 | -257.00 | -306.00 | -158.00 | -129.00 | -246.00 | -321.00 | -334.00 | -299.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 83 | 85 | 46 | 74 | 93 | 135 | 134 | 134 | 116 | 144 | 186 |
| Inventory Days | 124 | 68 | 77 | 146 | 90 | 63 | 33 | 56 | 79 | 108 | 76 | 154 |
| Days Payable | 35 | 34 | 14 | 18 | 24 | 16 | 21 | 27 | 32 | 25 | 9 | 11 |
| Cash Conversion Cycle | 137 | 117 | 148 | 174 | 140 | 140 | 147 | 164 | 182 | 198 | 210 | 329 |
| Working Capital Days | 29 | 32 | 44 | 43 | 13 | 10 | 31 | 49 | 55 | 63 | 81 | 123 |
| ROCE % | 10% | 12% | 7% | 9% | 11% | 10% | 17% | 19% | 28% | 16% | 12% | 12% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | 8.50 | 8.56 | 8.93 | 13.17 | 98.32 |
| Diluted EPS (Rs.) | 7.38 | 8.56 | 8.93 | 13.17 | 98.32 |
| Cash EPS (Rs.) | 9.00 | 9.15 | 9.54 | 13.64 | 100.10 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 64.95 | 50.75 | 42.19 | 33.71 | 348.87 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 65.27 | 51.08 | 42.51 | 34.03 | 353.82 |
| Dividend / Share (Rs.) | 0.00 | 0.00 | 0.45 | 2.65 | 20.00 |
| Revenue From Operations / Share (Rs.) | 152.19 | 197.64 | 210.41 | 183.07 | 1974.83 |
| PBDIT / Share (Rs.) | 15.09 | 15.23 | 16.24 | 20.32 | 161.44 |
| PBIT / Share (Rs.) | 14.60 | 14.64 | 15.63 | 19.82 | 154.30 |
| PBT / Share (Rs.) | 11.65 | 11.23 | 12.43 | 17.69 | 124.76 |
| Net Profit / Share (Rs.) | 8.50 | 8.56 | 8.93 | 13.14 | 92.96 |
| PBDIT Margin (%) | 9.91 | 7.70 | 7.71 | 11.09 | 8.17 |
| PBIT Margin (%) | 9.59 | 7.40 | 7.42 | 10.82 | 7.81 |
| PBT Margin (%) | 7.65 | 5.68 | 5.90 | 9.66 | 6.31 |
| Net Profit Margin (%) | 5.58 | 4.33 | 4.24 | 7.17 | 4.70 |
| Return on Networth / Equity (%) | 13.08 | 16.87 | 21.16 | 38.97 | 26.64 |
| Return on Capital Employeed (%) | 22.15 | 28.45 | 36.42 | 57.54 | 43.00 |
| Return On Assets (%) | 5.89 | 6.97 | 7.03 | 12.04 | 8.79 |
| Total Debt / Equity (X) | 0.93 | 1.29 | 1.61 | 1.64 | 1.36 |
| Asset Turnover Ratio (%) | 1.14 | 1.58 | 1.78 | 2.05 | 1.97 |
| Current Ratio (X) | 1.73 | 1.63 | 1.43 | 1.38 | 1.37 |
| Quick Ratio (X) | 1.09 | 1.14 | 0.82 | 0.95 | 1.04 |
| Inventory Turnover Ratio (X) | 3.55 | 4.56 | 4.60 | 6.74 | 8.36 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 5.04 | 20.16 | 26.55 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 4.71 | 19.42 | 24.65 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 94.96 | 79.84 | 73.45 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 95.29 | 80.58 | 75.35 |
| Interest Coverage Ratio (X) | 5.12 | 4.46 | 5.09 | 9.57 | 5.46 |
| Interest Coverage Ratio (Post Tax) (X) | 3.88 | 3.51 | 3.80 | 7.19 | 4.15 |
| Enterprise Value (Cr.) | 1906.74 | 1097.76 | 1506.25 | 4175.26 | 817.60 |
| EV / Net Operating Revenue (X) | 2.09 | 0.92 | 1.19 | 3.80 | 1.05 |
| EV / EBITDA (X) | 21.06 | 12.01 | 15.46 | 34.25 | 12.85 |
| MarketCap / Net Operating Revenue (X) | 1.73 | 0.60 | 0.87 | 3.50 | 0.81 |
| Retention Ratios (%) | 0.00 | 0.00 | 94.95 | 79.83 | 73.44 |
| Price / BV (X) | 4.05 | 2.34 | 4.35 | 19.02 | 4.60 |
| Price / Net Operating Revenue (X) | 1.73 | 0.60 | 0.87 | 3.50 | 0.81 |
| EarningsYield | 0.03 | 0.07 | 0.04 | 0.02 | 0.05 |
After reviewing the key financial ratios for GRM Overseas Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 8.56 (Mar 24) to 8.50, marking a decrease of 0.06.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.38. This value is within the healthy range. It has decreased from 8.56 (Mar 24) to 7.38, marking a decrease of 1.18.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.00. This value is within the healthy range. It has decreased from 9.15 (Mar 24) to 9.00, marking a decrease of 0.15.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.95. It has increased from 50.75 (Mar 24) to 64.95, marking an increase of 14.20.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 65.27. It has increased from 51.08 (Mar 24) to 65.27, marking an increase of 14.19.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 152.19. It has decreased from 197.64 (Mar 24) to 152.19, marking a decrease of 45.45.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 15.09. This value is within the healthy range. It has decreased from 15.23 (Mar 24) to 15.09, marking a decrease of 0.14.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.60. This value is within the healthy range. It has decreased from 14.64 (Mar 24) to 14.60, marking a decrease of 0.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.65. This value is within the healthy range. It has increased from 11.23 (Mar 24) to 11.65, marking an increase of 0.42.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 8.56 (Mar 24) to 8.50, marking a decrease of 0.06.
- For PBDIT Margin (%), as of Mar 25, the value is 9.91. This value is below the healthy minimum of 10. It has increased from 7.70 (Mar 24) to 9.91, marking an increase of 2.21.
- For PBIT Margin (%), as of Mar 25, the value is 9.59. This value is below the healthy minimum of 10. It has increased from 7.40 (Mar 24) to 9.59, marking an increase of 2.19.
- For PBT Margin (%), as of Mar 25, the value is 7.65. This value is below the healthy minimum of 10. It has increased from 5.68 (Mar 24) to 7.65, marking an increase of 1.97.
- For Net Profit Margin (%), as of Mar 25, the value is 5.58. This value is within the healthy range. It has increased from 4.33 (Mar 24) to 5.58, marking an increase of 1.25.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.08. This value is below the healthy minimum of 15. It has decreased from 16.87 (Mar 24) to 13.08, marking a decrease of 3.79.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.15. This value is within the healthy range. It has decreased from 28.45 (Mar 24) to 22.15, marking a decrease of 6.30.
- For Return On Assets (%), as of Mar 25, the value is 5.89. This value is within the healthy range. It has decreased from 6.97 (Mar 24) to 5.89, marking a decrease of 1.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.93. This value is within the healthy range. It has decreased from 1.29 (Mar 24) to 0.93, marking a decrease of 0.36.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 1.58 (Mar 24) to 1.14, marking a decrease of 0.44.
- For Current Ratio (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.63 (Mar 24) to 1.73, marking an increase of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.14 (Mar 24) to 1.09, marking a decrease of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.55. This value is below the healthy minimum of 4. It has decreased from 4.56 (Mar 24) to 3.55, marking a decrease of 1.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.12. This value is within the healthy range. It has increased from 4.46 (Mar 24) to 5.12, marking an increase of 0.66.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 3.51 (Mar 24) to 3.88, marking an increase of 0.37.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,906.74. It has increased from 1,097.76 (Mar 24) to 1,906.74, marking an increase of 808.98.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 2.09, marking an increase of 1.17.
- For EV / EBITDA (X), as of Mar 25, the value is 21.06. This value exceeds the healthy maximum of 15. It has increased from 12.01 (Mar 24) to 21.06, marking an increase of 9.05.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 0.60 (Mar 24) to 1.73, marking an increase of 1.13.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 4.05. This value exceeds the healthy maximum of 3. It has increased from 2.34 (Mar 24) to 4.05, marking an increase of 1.71.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 0.60 (Mar 24) to 1.73, marking an increase of 1.13.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.03, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in GRM Overseas Ltd:
- Net Profit Margin: 5.58%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.15% (Industry Average ROCE: 11.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.08% (Industry Average ROE: 12.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.09
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 59.2 (Industry average Stock P/E: 30.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.93
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.58%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | 128, First Floor, Shiva Market, Delhi Delhi 110034 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Atul Garg | Chairman & Managing Director |
| Mrs. Mamta Garg | Executive Director |
| Mr. Hukam Chand Garg | Non Executive Director |
| Mr. Nipun Jain | Non Executive Director |
| Mr. Raj Kumar Garg | Independent Director |
| Mr. Gautam Gupta | Independent Director |
| Mr. Tarun Singh | Independent Director |
| Ms. Nidhi | Independent Director |
FAQ
What is the intrinsic value of GRM Overseas Ltd?
GRM Overseas Ltd's intrinsic value (as of 14 January 2026) is ₹165.74 which is 2.51% lower the current market price of ₹170.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,135 Cr. market cap, FY2025-2026 high/low of ₹186/64.4, reserves of ₹420 Cr, and liabilities of ₹821 Cr.
What is the Market Cap of GRM Overseas Ltd?
The Market Cap of GRM Overseas Ltd is 3,135 Cr..
What is the current Stock Price of GRM Overseas Ltd as on 14 January 2026?
The current stock price of GRM Overseas Ltd as on 14 January 2026 is ₹170.
What is the High / Low of GRM Overseas Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of GRM Overseas Ltd stocks is ₹186/64.4.
What is the Stock P/E of GRM Overseas Ltd?
The Stock P/E of GRM Overseas Ltd is 59.2.
What is the Book Value of GRM Overseas Ltd?
The Book Value of GRM Overseas Ltd is 23.5.
What is the Dividend Yield of GRM Overseas Ltd?
The Dividend Yield of GRM Overseas Ltd is 0.00 %.
What is the ROCE of GRM Overseas Ltd?
The ROCE of GRM Overseas Ltd is 12.1 %.
What is the ROE of GRM Overseas Ltd?
The ROE of GRM Overseas Ltd is 14.6 %.
What is the Face Value of GRM Overseas Ltd?
The Face Value of GRM Overseas Ltd is 2.00.